Where does Gilead Apollo, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gilead Apollo, LLC ranks #17,699 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gilead Apollo, LLC hold?

Gilead Apollo, LLC holds 16 US utility patents granted between 2016 and 2024, spanning 8 technology areas.

What is Gilead Apollo, LLC's Innovation Score?

Gilead Apollo, LLC has an Innovation Score of 25.6 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Gilead Apollo, LLC focus on?

Gilead Apollo, LLC's top technology area is C07D (Heterocyclic Compounds) with 16 patents, ranking #537 of 3,165 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Gilead Apollo, LLC's patent grant rate increasing or decreasing?

Gilead Apollo, LLC's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Gilead Apollo, LLC's patents?

Gilead Apollo, LLC's patents average 8.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gilead Apollo, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Gilead Apollo, LLC

USPTO PatentsView assignee record - 16 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gilead ranks #17,699 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 8 technology areas.

#17,699
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.6/100): 8.8
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17699 · US Corporation #17,699 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,699/49,997
PHOTO-FINISH GenXComm
CPC-NARROW C07D · 8 areas
INNOV-THIN 25.6/100
CLAIMS-PAR 8.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: GenXComm, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gilead’s 25.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (38%) Velocity 0.6 pts (2%) Breadth 10.0 pts (39%) Claim depth 5.3 pts (21%)

Qualcomm Incorporated · highest

85
Gilead Apollo · this assignee

26
3D Lighting… · lowest

7

What this shows Gilead's Innovation Score is 25.6/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gilead?

Each dot is one of Gilead’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gilead’s own 8.8 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Gilead vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gilead's grants concentrate

Gilead Apollo, LLC is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2016. By volume, Gilead sits between GenXComm, Inc. and Global Products International Group, LLC.

Gilead's three-year grant acceleration

Gilead Apollo, LLC shows 1 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Genxcomm

16
Geospace

16
Gerhard D Wempe KG

16
Giatec Scientific

16
Givewith

16
Gizmospring com D…

16
Gliknik

16
Global Products I…

16
Gilead Apollo ◀

16

What this shows Gilead holds 16 patents at rank #17,706, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gilead

By rank, the assignees closest to #17,706 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Gilead's primary technology class.

Gilead's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Gilead Apollo, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.3%
2017	1	6.3%
2018	2	12.5%
2019	6	37.5%
2020	1	6.3%
2021	4	25.0%
2024	1	6.3%

Which technologies does Gilead Apollo, LLC patent most?

C07D - Heterocyclic Compounds 16

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C12Y - Enzymes 6

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gilead Apollo, LLC's patent record in context - here's where to go next.

Gilead Apollo, LLC's lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #17,699 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gilead Apollo, LLC against GenXComm, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.